Redefining the standard of care in metastatic leiomyosarcoma

Lancet Oncol. 2015 Apr;16(4):360-2. doi: 10.1016/S1470-2045(15)70107-5. Epub 2015 Mar 18.

Authors

Jonathan Noujaim¹, Winette T A van der Graaf², Robin L Jones³

Affiliations

¹ Sarcoma Unit, Royal Marsden Hospital, London SW3 6JJ, UK.
² Radboud University Medical Center, 6525 GA Nijmegen, Netherlands.
³ Sarcoma Unit, Royal Marsden Hospital, London SW3 6JJ, UK. Electronic address: [email protected].

PMID: 25795407
DOI: 10.1016/S1470-2045(15)70107-5

No abstract available

Publication types

Comment

MeSH terms

Dioxoles / administration & dosage*
Doxorubicin / administration & dosage*
Female
Humans
Leiomyosarcoma / drug therapy*
Male
Soft Tissue Neoplasms / drug therapy*
Tetrahydroisoquinolines / administration & dosage*
Uterine Neoplasms / drug therapy*

Substances

Dioxoles
Tetrahydroisoquinolines
Doxorubicin